Exact Mass: 549.3124
Exact Mass Matches: 549.3124
Found 399 metabolites which its exact mass value is equals to given mass value 549.3124
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Fluphenazine enanthate
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
Dhesn
Retinoyl-AZT
Val-Tyr-Leu-Arg
Ile Asp Phe Arg
Phe Lys Gln Lys
Ile Tyr Val Arg
Ile Phe Asp Arg
Asp Phe Ile Arg
Asp Phe Leu Arg
Asp Phe Arg Ile
Asp Phe Arg Leu
Asp Ile Phe Arg
Asp Ile Arg Phe
Asp Leu Phe Arg
Asp Leu Arg Phe
Asp Arg Phe Ile
Asp Arg Phe Leu
Asp Arg Ile Phe
Asp Arg Leu Phe
Glu Phe Arg Val
Glu Phe Val Arg
Glu His His Lys
Glu His Lys His
Glu Lys His His
Glu Arg Phe Val
Glu Arg Val Phe
Glu Val Phe Arg
Glu Val Arg Phe
Phe Asp Ile Arg
Phe Asp Leu Arg
Phe Asp Arg Ile
Phe Asp Arg Leu
Phe Glu Arg Val
Phe Glu Val Arg
Phe Ile Asp Arg
Phe Ile Arg Asp
Phe Lys Lys Gln
Phe Lys Gln Gln
Phe Leu Asp Arg
Phe Leu Arg Asp
Phe Met Pro Arg
Phe Met Arg Pro
Phe Asn Asn Arg
Phe Asn Arg Asn
Phe Pro Met Arg
Phe Pro Arg Met
Phe Gln Lys Lys
Phe Gln Lys Gln
Phe Gln Gln Lys
Phe Arg Asp Ile
Phe Arg Asp Leu
Phe Arg Glu Val
Phe Arg Ile Asp
Phe Arg Leu Asp
Phe Arg Met Pro
Phe Arg Asn Asn
Phe Arg Pro Met
Phe Arg Val Glu
Phe Val Glu Arg
Phe Val Arg Glu
Phe Val Val Trp
Phe Val Trp Val
Phe Trp Val Val
His Glu His Lys
His Glu Lys His
His His Glu Lys
His His Lys Glu
His His Arg Thr
His His Thr Arg
His Lys Glu His
His Lys His Glu
His Arg His Thr
His Arg Thr His
His Thr His Arg
His Thr Arg His
Ile Asp Arg Phe
Ile Phe Arg Asp
Ile Met Met Arg
Ile Met Arg Met
Ile Arg Asp Phe
Ile Arg Phe Asp
Ile Arg Met Met
Ile Arg Val Tyr
Ile Arg Tyr Val
Ile Val Arg Tyr
Ile Val Tyr Arg
Ile Tyr Arg Val
Lys Glu His His
Lys Phe Lys Gln
Lys Phe Gln Lys
Lys Phe Gln Gln
Lys His Glu His
Lys His His Glu
Lys Lys Phe Gln
Lys Lys Gln Phe
Lys Gln Phe Lys
Lys Gln Phe Gln
Lys Gln Lys Phe
Lys Gln Gln Phe
Leu Asp Phe Arg
Leu Asp Arg Phe
Leu Phe Asp Arg
Leu Phe Arg Asp
Leu Met Met Arg
Leu Met Arg Met
Leu Arg Asp Phe
Leu Arg Phe Asp
Leu Arg Met Met
Leu Arg Val Tyr
Leu Arg Tyr Val
Leu Val Arg Tyr
Leu Val Tyr Arg
Leu Tyr Arg Val
Leu Tyr Val Arg
Met Phe Pro Arg
Met Phe Arg Pro
Met Ile Met Arg
Met Ile Arg Met
Met Leu Met Arg
Met Leu Arg Met
Met Met Ile Arg
Met Met Leu Arg
Met Met Arg Ile
Met Met Arg Leu
Met Pro Phe Arg
Met Pro Arg Phe
Met Arg Phe Pro
Met Arg Ile Met
Met Arg Leu Met
Met Arg Met Ile
Met Arg Met Leu
Met Arg Pro Phe
Asn Phe Asn Arg
Asn Phe Arg Asn
Asn Asn Phe Arg
Asn Asn Arg Phe
Asn Arg Phe Asn
Asn Arg Asn Phe
Pro Phe Met Arg
Pro Phe Arg Met
Pro Met Phe Arg
Pro Met Arg Phe
Pro Arg Phe Met
Pro Arg Met Phe
Gln Phe Lys Lys
Gln Phe Lys Gln
Gln Phe Gln Lys
Gln Lys Phe Lys
Gln Lys Phe Gln
Gln Lys Lys Phe
Gln Lys Gln Phe
Gln Gln Phe Lys
Gln Gln Lys Phe
Arg Asp Phe Ile
Arg Asp Phe Leu
Arg Asp Ile Phe
Arg Asp Leu Phe
Arg Glu Phe Val
Arg Glu Val Phe
Arg Phe Asp Ile
Arg Phe Asp Leu
Arg Phe Glu Val
Arg Phe Ile Asp
Arg Phe Leu Asp
Arg Phe Met Pro
Arg Phe Asn Asn
Arg Phe Pro Met
Arg Phe Val Glu
Arg His His Thr
Arg His Thr His
Arg Ile Asp Phe
Arg Ile Phe Asp
Arg Ile Met Met
Arg Ile Val Tyr
Arg Ile Tyr Val
Arg Leu Asp Phe
Arg Leu Phe Asp
Arg Leu Met Met
Arg Leu Val Tyr
Arg Leu Tyr Val
Arg Met Phe Pro
Arg Met Ile Met
Arg Met Leu Met
Arg Met Met Ile
Arg Met Met Leu
Arg Met Pro Phe
Arg Asn Phe Asn
Arg Asn Asn Phe
Arg Pro Phe Met
Arg Pro Met Phe
Arg Thr His His
Arg Val Glu Phe
Arg Val Phe Glu
Arg Val Ile Tyr
Arg Val Leu Tyr
Arg Val Tyr Ile
Arg Val Tyr Leu
Arg Tyr Ile Val
Arg Tyr Leu Val
Arg Tyr Val Ile
Arg Tyr Val Leu
Thr His His Arg
Thr His Arg His
Thr Arg His His
Val Glu Phe Arg
Val Glu Arg Phe
Val Phe Glu Arg
Val Phe Arg Glu
Val Phe Val Trp
Val Phe Trp Val
Val Ile Arg Tyr
Val Ile Tyr Arg
Val Leu Arg Tyr
Val Leu Tyr Arg
Val Arg Glu Phe
Val Arg Phe Glu
Val Arg Ile Tyr
Val Arg Leu Tyr
Val Arg Tyr Ile
Val Arg Tyr Leu
Val Val Phe Trp
Val Val Trp Phe
Val Trp Phe Val
Val Trp Val Phe
Val Tyr Ile Arg
Val Tyr Leu Arg
Val Tyr Arg Ile
Val Tyr Arg Leu
Trp Phe Val Val
Trp Val Phe Val
Trp Val Val Phe
Tyr Ile Arg Val
Tyr Ile Val Arg
Tyr Leu Arg Val
Tyr Leu Val Arg
Tyr Arg Ile Val
Tyr Arg Leu Val
Tyr Arg Val Ile
Tyr Arg Val Leu
Tyr Val Ile Arg
Tyr Val Leu Arg
Tyr Val Arg Ile
Tyr Val Arg Leu
PC(16:0/3:1)
TERT-BUTYL ((1S,3S)-1-((2S,4S)-4-ISOPROPYL-5-OXOTETRAHYDROFURAN-2-YL)-3-(4-METHOXY-3-(3-METHOXYPROPOXY)BENZOYL)-4-METHYLPENTYL)CARBAMATE
ETHYL 4-[4-[4-(HYDROXYDIPHENYLMETHYL)-1-PIPERIDINYL]-1
(1R-(1alpha,4abeta,10aalpha))-3,3-(((1,2,3,4,9,10,10a-Octahydro-1,4a-dimethyl-7-(1-methylethyl)-1-phenanthryl)methyl)imino)bispropiophenone
(S)-6-phenyl-3,10-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6H-benzo[5,6][1,3]oxazino[3,4-a]indole
DI-tert-butyl (2S,3S,4R)-4-((3-(1,1-difluoroallyl)-7-methoxyquinoxalin-2-yl)oxy)-3-ethylpyrrolidine-1,2-dicarboxylate
2-[(5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oyl]-sn-glycero-3-phosphoethanolamine
A 2-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oyl
[3-azido-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoate
2-azaniumylethyl (2R)-2-{[(5Z,11alpha,13E,15S)-11,15-dihydroxy-1,9-dioxoprosta-5,13-dien-1-yl]oxy}-3-hydroxypropyl phosphate
2-azaniumylethyl (2R)-3-hydroxy-2-{[(5Z)-7-{(1R,4S,5R,6R)-6-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-2,3-dioxabicyclo[2.2.1]heptan-5-yl}hept-5-enoyl]oxy}propyl phosphate
(2R)-1-{[(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-3-hydroxypropan-2-yl (5Z)-7-{(1R,4S,5R,6R)-6-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-2,3-dioxabicyclo[2.2.1]heptan-5-yl}hept-5-enoate
(2R,3S)-2-(Cyanomethyl)-3-[benzyl[(R)-alpha-methylbenzyl]amino]-3-[2-(diallylamino)phenyl]propanoic acid tert-butyl ester
2-amino-3-[hydroxy-[2-hydroxy-3-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropoxy]phosphoryl]oxypropanoic acid
3-[[3-acetyloxy-2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxy-2-aminopropanoic acid
(E)-3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]tridec-4-ene-1-sulfonic acid
(4E,8E,12E)-2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxypentadeca-4,8,12-triene-1-sulfonic acid
(4E,8E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]amino]trideca-4,8-diene-1-sulfonic acid
(4E,8E)-2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxypentadeca-4,8-diene-1-sulfonic acid
(E)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]undec-4-ene-1-sulfonic acid
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] (Z)-tridec-9-enoate
2-amino-3-[[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-propanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-butanoyloxypropan-2-yl] (Z)-octadec-9-enoate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] (Z)-pentadec-9-enoate
[3-hexanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (Z)-nonadec-9-enoate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (Z)-heptadec-9-enoate
[1-acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-icos-11-enoate
[2-[(Z)-hexadec-9-enoyl]oxy-3-propanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] (Z)-hexadec-9-enoate
[3-pentanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] (Z)-tetradec-9-enoate
[3-butanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-acetyloxy-2-[(Z)-heptadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
fluphenazine enanthate
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
1-hexadecanoyl-2-(2E-propionyl)-sn-glycero-3-phosphocholine
2-[(5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oyl]-sn-glycero-3-phosphoethanolamine zwitterion
A 2-acyl-sn-glycero-3-phosphoethanolamine zwitterion obtained by transfer of a proton from the phosphate to the amino group of 2-[(5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oyl]-sn-glycero-3-phosphoethanolamine; major species at pH 7.3.
2-[(9S,11R)-epidioxy-(15S)-hydroxy-(5Z,13E)-prostadienoyl]-sn-glycero-3-phosphoethanolamine zwitterion
A 2-acyl-sn-glycero-3-phosphoethanolamine zwitterion obtained by transfer of a proton from the phosphate to the amino group of 2-[(9S,11R)-epidioxy-(15S)-hydroxy-(5Z,13E)-prostadienoyl]-sn-glycero-3-phosphoethanolamine; major species at pH 7.3.
2-[(9S,11R)-epidioxy-(15S)-hydroxy-(5Z,13E)-prostadienoyl]-sn-glycero-3-phosphoethanolamine
A 2-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as (9S,11R)-epidioxy-(15S)-hydroxy-(5Z,13E)-prostadienoyl.
MePC(18:1)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
PE(22:1)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
(3s,6s,9s,16r,21as)-3-ethyl-1,10-dihydroxy-6-isopropyl-5,8,9-trimethyl-16-(prop-2-en-1-yl)-3h,6h,9h,12h,13h,16h,19h,20h,21h,21ah-pyrrolo[1,2-d]1-oxa-4,7,10,13,16-pentaazacyclononadecane-4,7,14,17-tetrone
(2s,12bs)-3-ethenyl-2-{[(1s)-2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]methyl}-11-[(2s)-1-methylpyrrolidin-2-yl]-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-10-ol
(2s,3r,12bs)-3-ethenyl-2-{[(1s)-2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]methyl}-11-[(2s)-1-methylpyrrolidin-2-yl]-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-10-ol
(2s,3r,12bs)-3-ethenyl-2-{[(1s)-2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]methyl}-11-[(2r)-1-methylpyrrolidin-2-yl]-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-10-ol
asperulosidic acid_qt
{"Ingredient_id": "HBIN017143","Ingredient_name": "asperulosidic acid_qt","Alias": "NA","Ingredient_formula": "C32H39NO7","Ingredient_Smile": "NA","Ingredient_weight": "549.65","OB_score": "55.55587601","CAS_id": "25374-68-9","SymMap_id": "SMIT11614","TCMID_id": "NA","TCMSP_id": "MOL010593","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}